Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07462897
NA

Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years

Sponsor: Essilor International

View on ClinicalTrials.gov

Summary

The goal of this clinical investigation is to learn how much a new generation of myopia control lens (MCL1 - Myopia Control Lens 1) is helpful in reducing myopia progression in children from 6 to 14 yo. The main questions it aims to answer is: How much this new generation of lens, called MCL1, slows down the growth of the eye? Researchers will compare MCL1 to a former generation of myopia control lens (i.e. MCL2) but with better vision quality. Participants will: * Wear MCL1 on right eye and MCL2 on left eye for 6 months and MCL2 on rigth eye and MCL1 on left eye for the next 6 months; * Visit the hospital at 6 and 12 months for tests; * Answer weekly questionnaires on compliance wearing glasses, quality of vision and out-of-school activities.

Official title: Evaluation of the Effectiveness of a New Generation of Myopia Control Lens, Producing a Higher Myopic Control Signal Than That Produced by a Previous Generation Lens, on the Progression of Myopia in Children Aged 6 to 14 Years

Key Details

Gender

All

Age Range

6 Years - 14 Years

Study Type

INTERVENTIONAL

Enrollment

76

Start Date

2026-03

Completion Date

2028-05

Last Updated

2026-03-10

Healthy Volunteers

No

Interventions

DEVICE

MCL1

Myopia Control Lens 1 (MCL 1) is an ophthalmic lens intended to slow down eye growth in children.

DEVICE

MCL2

Myopia Control Lens 2 (MCL 2) is an ophthalmic lens intended to slow down eye growth in children.

Locations (1)

Département d'Ophtalmologie, Hôpital Fondation Adolphe de Rothschild

Paris, France